PNO..Pharmanet.. .005c recently relaunched thermalife pain relief cream to australian market, 2 more products within 3 months...licesnse deals possible, plus new products to be added... With the patents it holds, and potential of the tripeptofen platform could be a multi, multi bagger.. MD recently bought 30 million at .005c.. recent cap raise has subdued the price.. Thermalife is a competitor to voltaren, and its safe . Chemist warehouse is now stocking the product...as sales start increasing market cap (6mill) will rise substantially.
